nodes	percent_of_prediction	percent_of_DWPC	metapath
Cysteamine—SST—portal vein—hepatitis B	0.273	0.637	CbGeAlD
Cysteamine—SST—blood plasma—hepatitis B	0.048	0.112	CbGeAlD
Cysteamine—MPO—saliva—hepatitis B	0.0445	0.104	CbGeAlD
Cysteamine—Skin odour abnormal—Lamivudine—hepatitis B	0.0194	0.0486	CcSEcCtD
Cysteamine—MPO—blood plasma—hepatitis B	0.0193	0.0451	CbGeAlD
Cysteamine—SST—blood—hepatitis B	0.0176	0.041	CbGeAlD
Cysteamine—SST—liver—hepatitis B	0.0138	0.0321	CbGeAlD
Cysteamine—Hepatic function abnormal—Adefovir Dipivoxil—hepatitis B	0.00999	0.025	CcSEcCtD
Cysteamine—Liver function test abnormal—Adefovir Dipivoxil—hepatitis B	0.00806	0.0202	CcSEcCtD
Cysteamine—Pain in extremity—Telbivudine—hepatitis B	0.00735	0.0184	CcSEcCtD
Cysteamine—MPO—blood—hepatitis B	0.00709	0.0165	CbGeAlD
Cysteamine—Renal failure—Entecavir—hepatitis B	0.00678	0.017	CcSEcCtD
Cysteamine—Renal failure—Adefovir Dipivoxil—hepatitis B	0.00662	0.0165	CcSEcCtD
Cysteamine—Bone disorder—Lamivudine—hepatitis B	0.00632	0.0158	CcSEcCtD
Cysteamine—MPO—Selenium Micronutrient Network—GGT2—hepatitis B	0.00621	0.0363	CbGpPWpGaD
Cysteamine—NPY2R—Peptide GPCRs—CCR5—hepatitis B	0.00607	0.0355	CbGpPWpGaD
Cysteamine—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00597	0.0149	CcSEcCtD
Cysteamine—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00594	0.0148	CcSEcCtD
Cysteamine—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00592	0.0148	CcSEcCtD
Cysteamine—Immune system disorder—Entecavir—hepatitis B	0.00559	0.014	CcSEcCtD
Cysteamine—Renal failure—Telbivudine—hepatitis B	0.00557	0.0139	CcSEcCtD
Cysteamine—MPO—liver—hepatitis B	0.00554	0.0129	CbGeAlD
Cysteamine—Mental disorder—Entecavir—hepatitis B	0.00543	0.0136	CcSEcCtD
Cysteamine—Malnutrition—Entecavir—hepatitis B	0.00539	0.0135	CcSEcCtD
Cysteamine—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00526	0.0131	CcSEcCtD
Cysteamine—Connective tissue disorder—Telbivudine—hepatitis B	0.005	0.0125	CcSEcCtD
Cysteamine—MPO—IL23-mediated signaling events—IL18—hepatitis B	0.00487	0.0285	CbGpPWpGaD
Cysteamine—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00486	0.0122	CcSEcCtD
Cysteamine—Leukopenia—Entecavir—hepatitis B	0.00483	0.0121	CcSEcCtD
Cysteamine—Gastroenteritis—Lamivudine—hepatitis B	0.00468	0.0117	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00456	0.0114	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00445	0.0111	CcSEcCtD
Cysteamine—Malnutrition—Telbivudine—hepatitis B	0.00443	0.0111	CcSEcCtD
Cysteamine—Anaphylactic shock—Entecavir—hepatitis B	0.0044	0.011	CcSEcCtD
Cysteamine—Nervous system disorder—Entecavir—hepatitis B	0.00431	0.0108	CcSEcCtD
Cysteamine—Skin disorder—Entecavir—hepatitis B	0.00427	0.0107	CcSEcCtD
Cysteamine—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00421	0.0105	CcSEcCtD
Cysteamine—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00417	0.0104	CcSEcCtD
Cysteamine—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00409	0.0102	CcSEcCtD
Cysteamine—Affect lability—Lamivudine—hepatitis B	0.00408	0.0102	CcSEcCtD
Cysteamine—Mood swings—Lamivudine—hepatitis B	0.00393	0.00982	CcSEcCtD
Cysteamine—Somnolence—Entecavir—hepatitis B	0.00391	0.00978	CcSEcCtD
Cysteamine—Dyspepsia—Entecavir—hepatitis B	0.00387	0.00968	CcSEcCtD
Cysteamine—Dehydration—Lamivudine—hepatitis B	0.00385	0.00964	CcSEcCtD
Cysteamine—SST—SIDS Susceptibility Pathways—IL10—hepatitis B	0.00385	0.0225	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—CXCL10—hepatitis B	0.00384	0.0225	CbGpPWpGaD
Cysteamine—Liver function test abnormal—Lamivudine—hepatitis B	0.00383	0.00957	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Entecavir—hepatitis B	0.0038	0.0095	CcSEcCtD
Cysteamine—Fatigue—Entecavir—hepatitis B	0.00379	0.00948	CcSEcCtD
Cysteamine—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00378	0.00945	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00374	0.00936	CcSEcCtD
Cysteamine—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00373	0.00933	CcSEcCtD
Cysteamine—Discomfort—Telbivudine—hepatitis B	0.00373	0.00931	CcSEcCtD
Cysteamine—MPO—IL23-mediated signaling events—NOS2—hepatitis B	0.00372	0.0218	CbGpPWpGaD
Cysteamine—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00371	0.00927	CcSEcCtD
Cysteamine—NPY2R—Peptide ligand-binding receptors—CXCL10—hepatitis B	0.00368	0.0215	CbGpPWpGaD
Cysteamine—Gastrointestinal pain—Entecavir—hepatitis B	0.0036	0.00899	CcSEcCtD
Cysteamine—Nervous system disorder—Telbivudine—hepatitis B	0.00354	0.00886	CcSEcCtD
Cysteamine—Skin disorder—Telbivudine—hepatitis B	0.00351	0.00878	CcSEcCtD
Cysteamine—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00351	0.00878	CcSEcCtD
Cysteamine—Body temperature increased—Entecavir—hepatitis B	0.00348	0.0087	CcSEcCtD
Cysteamine—Abdominal pain—Entecavir—hepatitis B	0.00348	0.0087	CcSEcCtD
Cysteamine—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00339	0.00848	CcSEcCtD
Cysteamine—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00339	0.00848	CcSEcCtD
Cysteamine—SST—G alpha (i) signalling events—CXCL10—hepatitis B	0.00324	0.0189	CbGpPWpGaD
Cysteamine—Dyspepsia—Telbivudine—hepatitis B	0.00318	0.00795	CcSEcCtD
Cysteamine—Asthenia—Entecavir—hepatitis B	0.00316	0.00789	CcSEcCtD
Cysteamine—Renal failure—Lamivudine—hepatitis B	0.00314	0.00785	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00312	0.0078	CcSEcCtD
Cysteamine—Fatigue—Telbivudine—hepatitis B	0.00312	0.00779	CcSEcCtD
Cysteamine—NPY2R—G alpha (i) signalling events—CXCL10—hepatitis B	0.0031	0.0182	CbGpPWpGaD
Cysteamine—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00308	0.0077	CcSEcCtD
Cysteamine—Diarrhoea—Entecavir—hepatitis B	0.00301	0.00753	CcSEcCtD
Cysteamine—Feeling abnormal—Telbivudine—hepatitis B	0.00298	0.00745	CcSEcCtD
Cysteamine—SST—Peptide ligand-binding receptors—CCR5—hepatitis B	0.00298	0.0174	CbGpPWpGaD
Cysteamine—Gastrointestinal pain—Telbivudine—hepatitis B	0.00296	0.00739	CcSEcCtD
Cysteamine—MPO—Selenium Micronutrient Network—GGT1—hepatitis B	0.00294	0.0172	CbGpPWpGaD
Cysteamine—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00294	0.00734	CcSEcCtD
Cysteamine—MPO—Vitamin B12 Metabolism—F2—hepatitis B	0.00291	0.017	CbGpPWpGaD
Cysteamine—Dizziness—Entecavir—hepatitis B	0.00291	0.00727	CcSEcCtD
Cysteamine—Body temperature increased—Telbivudine—hepatitis B	0.00286	0.00714	CcSEcCtD
Cysteamine—Abdominal pain—Telbivudine—hepatitis B	0.00286	0.00714	CcSEcCtD
Cysteamine—NPY2R—Peptide ligand-binding receptors—CCR5—hepatitis B	0.00285	0.0167	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—IFNG—hepatitis B	0.00285	0.0167	CbGpPWpGaD
Cysteamine—Connective tissue disorder—Lamivudine—hepatitis B	0.00282	0.00704	CcSEcCtD
Cysteamine—Vomiting—Entecavir—hepatitis B	0.0028	0.00699	CcSEcCtD
Cysteamine—Rash—Entecavir—hepatitis B	0.00277	0.00694	CcSEcCtD
Cysteamine—Dermatitis—Entecavir—hepatitis B	0.00277	0.00693	CcSEcCtD
Cysteamine—Headache—Entecavir—hepatitis B	0.00276	0.00689	CcSEcCtD
Cysteamine—MPO—IL23-mediated signaling events—CD4—hepatitis B	0.00275	0.0161	CbGpPWpGaD
Cysteamine—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00273	0.00682	CcSEcCtD
Cysteamine—Rash—Adefovir Dipivoxil—hepatitis B	0.00271	0.00677	CcSEcCtD
Cysteamine—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.0027	0.00676	CcSEcCtD
Cysteamine—NPY2R—Circadian rythm related genes—FAS—hepatitis B	0.0027	0.0158	CbGpPWpGaD
Cysteamine—Headache—Adefovir Dipivoxil—hepatitis B	0.00269	0.00672	CcSEcCtD
Cysteamine—Nausea—Entecavir—hepatitis B	0.00261	0.00653	CcSEcCtD
Cysteamine—Asthenia—Telbivudine—hepatitis B	0.00259	0.00648	CcSEcCtD
Cysteamine—Immune system disorder—Lamivudine—hepatitis B	0.00259	0.00647	CcSEcCtD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.00257	0.0151	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—F2—hepatitis B	0.00255	0.0149	CbGpPWpGaD
Cysteamine—Nausea—Adefovir Dipivoxil—hepatitis B	0.00255	0.00637	CcSEcCtD
Cysteamine—MPO—IL23-mediated signaling events—IL2—hepatitis B	0.00253	0.0148	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—CCR5—hepatitis B	0.00251	0.0147	CbGpPWpGaD
Cysteamine—Erythema—Lamivudine—hepatitis B	0.0025	0.00624	CcSEcCtD
Cysteamine—Malnutrition—Lamivudine—hepatitis B	0.0025	0.00624	CcSEcCtD
Cysteamine—Diarrhoea—Telbivudine—hepatitis B	0.00247	0.00618	CcSEcCtD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.00247	0.0144	CbGpPWpGaD
Cysteamine—Tension—Lamivudine—hepatitis B	0.00245	0.00612	CcSEcCtD
Cysteamine—NPY2R—Peptide ligand-binding receptors—F2—hepatitis B	0.00245	0.0143	CbGpPWpGaD
Cysteamine—Nervousness—Lamivudine—hepatitis B	0.00242	0.00606	CcSEcCtD
Cysteamine—MPO—Vitamin B12 Metabolism—ALB—hepatitis B	0.00242	0.0141	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—CCR5—hepatitis B	0.00241	0.0141	CbGpPWpGaD
Cysteamine—Dizziness—Telbivudine—hepatitis B	0.00239	0.00598	CcSEcCtD
Cysteamine—MPO—IL23-mediated signaling events—NFKB1—hepatitis B	0.00237	0.0139	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—F2—hepatitis B	0.00237	0.0139	CbGpPWpGaD
Cysteamine—Tremor—Lamivudine—hepatitis B	0.00234	0.00585	CcSEcCtD
Cysteamine—NPY2R—Circadian rythm related genes—NOS2—hepatitis B	0.00231	0.0135	CbGpPWpGaD
Cysteamine—Anaemia—Lamivudine—hepatitis B	0.00231	0.00577	CcSEcCtD
Cysteamine—Vomiting—Telbivudine—hepatitis B	0.0023	0.00575	CcSEcCtD
Cysteamine—Rash—Telbivudine—hepatitis B	0.00228	0.0057	CcSEcCtD
Cysteamine—Dermatitis—Telbivudine—hepatitis B	0.00228	0.00569	CcSEcCtD
Cysteamine—Headache—Telbivudine—hepatitis B	0.00226	0.00566	CcSEcCtD
Cysteamine—Leukopenia—Lamivudine—hepatitis B	0.00223	0.00559	CcSEcCtD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	0.00223	0.0131	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—IFNG—hepatitis B	0.00221	0.0129	CbGpPWpGaD
Cysteamine—Convulsion—Lamivudine—hepatitis B	0.00216	0.00541	CcSEcCtD
Cysteamine—Nausea—Telbivudine—hepatitis B	0.00215	0.00537	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00211	0.00528	CcSEcCtD
Cysteamine—Discomfort—Lamivudine—hepatitis B	0.0021	0.00525	CcSEcCtD
Cysteamine—Confusional state—Lamivudine—hepatitis B	0.00205	0.00513	CcSEcCtD
Cysteamine—Anaphylactic shock—Lamivudine—hepatitis B	0.00204	0.00509	CcSEcCtD
Cysteamine—Nervous system disorder—Lamivudine—hepatitis B	0.002	0.00499	CcSEcCtD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.002	0.0117	CbGpPWpGaD
Cysteamine—Skin disorder—Lamivudine—hepatitis B	0.00198	0.00495	CcSEcCtD
Cysteamine—MPO—Folate Metabolism—ALB—hepatitis B	0.00197	0.0115	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CXCL10—hepatitis B	0.00196	0.0115	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	0.00194	0.0114	CbGpPWpGaD
Cysteamine—Anorexia—Lamivudine—hepatitis B	0.00194	0.00485	CcSEcCtD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.00191	0.0112	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—NFKB1—hepatitis B	0.00189	0.011	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—F2—hepatitis B	0.00188	0.011	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CXCL10—hepatitis B	0.00188	0.011	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—TNF—hepatitis B	0.00185	0.0108	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—NFKB1—hepatitis B	0.00184	0.0107	CbGpPWpGaD
Cysteamine—Somnolence—Lamivudine—hepatitis B	0.00181	0.00453	CcSEcCtD
Cysteamine—MPO—Folate Metabolism—IFNG—hepatitis B	0.00179	0.0105	CbGpPWpGaD
Cysteamine—Dyspepsia—Lamivudine—hepatitis B	0.00179	0.00448	CcSEcCtD
Cysteamine—Decreased appetite—Lamivudine—hepatitis B	0.00177	0.00443	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00176	0.0044	CcSEcCtD
Cysteamine—Fatigue—Lamivudine—hepatitis B	0.00176	0.00439	CcSEcCtD
Cysteamine—Constipation—Lamivudine—hepatitis B	0.00174	0.00435	CcSEcCtD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.00171	0.01	CbGpPWpGaD
Cysteamine—Feeling abnormal—Lamivudine—hepatitis B	0.00168	0.0042	CcSEcCtD
Cysteamine—Gastrointestinal pain—Lamivudine—hepatitis B	0.00167	0.00416	CcSEcCtD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.00164	0.00961	CbGpPWpGaD
Cysteamine—Urticaria—Lamivudine—hepatitis B	0.00162	0.00405	CcSEcCtD
Cysteamine—Abdominal pain—Lamivudine—hepatitis B	0.00161	0.00403	CcSEcCtD
Cysteamine—Body temperature increased—Lamivudine—hepatitis B	0.00161	0.00403	CcSEcCtD
Cysteamine—MPO—Folate Metabolism—IL2—hepatitis B	0.00159	0.00933	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—ALB—hepatitis B	0.00156	0.00914	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CCR5—hepatitis B	0.00152	0.00889	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—CDKN2A—hepatitis B	0.00152	0.00888	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—RIT2—hepatitis B	0.00151	0.00881	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—SAG—hepatitis B	0.00151	0.00881	CbGpPWpGaD
Cysteamine—Hypersensitivity—Lamivudine—hepatitis B	0.0015	0.00375	CcSEcCtD
Cysteamine—MPO—Folate Metabolism—NFKB1—hepatitis B	0.00149	0.00874	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—IL6—hepatitis B	0.00149	0.00872	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—PTEN—hepatitis B	0.00148	0.00868	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—TNF—hepatitis B	0.00147	0.00858	CbGpPWpGaD
Cysteamine—Asthenia—Lamivudine—hepatitis B	0.00146	0.00365	CcSEcCtD
Cysteamine—NPY2R—GPCR ligand binding—CCR5—hepatitis B	0.00146	0.00853	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—SAG—hepatitis B	0.00144	0.00844	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—RIT2—hepatitis B	0.00144	0.00844	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—CD4—hepatitis B	0.00143	0.00836	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—TNF—hepatitis B	0.00143	0.00836	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—IFNG—hepatitis B	0.00143	0.00834	CbGpPWpGaD
Cysteamine—Diarrhoea—Lamivudine—hepatitis B	0.00139	0.00348	CcSEcCtD
Cysteamine—Dizziness—Lamivudine—hepatitis B	0.00135	0.00337	CcSEcCtD
Cysteamine—SST—GPCR ligand binding—F2—hepatitis B	0.0013	0.00763	CbGpPWpGaD
Cysteamine—Vomiting—Lamivudine—hepatitis B	0.0013	0.00324	CcSEcCtD
Cysteamine—Rash—Lamivudine—hepatitis B	0.00128	0.00321	CcSEcCtD
Cysteamine—Dermatitis—Lamivudine—hepatitis B	0.00128	0.00321	CcSEcCtD
Cysteamine—Headache—Lamivudine—hepatitis B	0.00128	0.00319	CcSEcCtD
Cysteamine—NPY2R—GPCR ligand binding—F2—hepatitis B	0.00125	0.00732	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—CDKN1A—hepatitis B	0.00124	0.00726	CbGpPWpGaD
Cysteamine—Nausea—Lamivudine—hepatitis B	0.00121	0.00302	CcSEcCtD
Cysteamine—MPO—Selenium Micronutrient Network—NFKB1—hepatitis B	0.00119	0.00694	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—IL6—hepatitis B	0.00118	0.00692	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—TNF—hepatitis B	0.00116	0.0068	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—IL6—hepatitis B	0.00115	0.00674	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—CXCL10—hepatitis B	0.00111	0.00648	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—CXCL10—hepatitis B	0.00106	0.00621	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—TP53—hepatitis B	0.00102	0.00599	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—TP53—hepatitis B	0.00101	0.00592	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CXCL10—hepatitis B	0.00101	0.00589	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CXCL10—hepatitis B	0.000964	0.00564	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—IL6—hepatitis B	0.000937	0.00549	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—IL6—hepatitis B	0.000926	0.00542	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—TNF—hepatitis B	0.000923	0.0054	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—CCR5—hepatitis B	0.000859	0.00503	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—CCR5—hepatitis B	0.000824	0.00482	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CCR5—hepatitis B	0.00078	0.00456	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CCR5—hepatitis B	0.000748	0.00438	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—IL6—hepatitis B	0.000745	0.00436	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—F2—hepatitis B	0.000737	0.00431	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—F2—hepatitis B	0.000707	0.00413	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—F2—hepatitis B	0.000669	0.00392	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—F2—hepatitis B	0.000642	0.00375	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CXCL10—hepatitis B	0.000594	0.00348	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CXCL10—hepatitis B	0.00057	0.00333	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—IL2—hepatitis B	0.000496	0.0029	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—IL2—hepatitis B	0.000476	0.00278	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CCR5—hepatitis B	0.000461	0.0027	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—IL2—hepatitis B	0.000451	0.00264	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCR5—hepatitis B	0.000442	0.00259	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—IL2—hepatitis B	0.000432	0.00253	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—F2—hepatitis B	0.000395	0.00231	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—F2—hepatitis B	0.000379	0.00222	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IL2—hepatitis B	0.000266	0.00156	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—IL6—hepatitis B	0.000265	0.00155	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CTNNB1—hepatitis B	0.000257	0.0015	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL2—hepatitis B	0.000255	0.00149	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—IL6—hepatitis B	0.000254	0.00149	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CDKN1A—hepatitis B	0.000251	0.00147	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PTEN—hepatitis B	0.000251	0.00147	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NFKB1—hepatitis B	0.000249	0.00146	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CTNNB1—hepatitis B	0.000246	0.00144	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CDKN1A—hepatitis B	0.000241	0.00141	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PTEN—hepatitis B	0.00024	0.00141	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NFKB1—hepatitis B	0.000239	0.0014	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TGFB1—hepatitis B	0.000208	0.00122	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TGFB1—hepatitis B	0.000199	0.00117	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TP53—hepatitis B	0.000171	0.001	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TP53—hepatitis B	0.000164	0.000959	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IL6—hepatitis B	0.000156	0.000916	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL6—hepatitis B	0.00015	0.000878	CbGpPWpGaD
